Geoffrey von Maltzahn ’03, PhD ’10 is an inventor, entrepreneur, and cofounder of more than ten first-in-category life science companies. A general partner at Flagship Pioneering, Geoff builds companies that integrate biology and data science to transform human health and environmental sustainability.

Geoff has deep expertise in genome engineering, bioengineering, the microbiome, and nanotechnology. He is listed as an inventor on over 200 patent applications and patents and has co-authored more than 20 peer-reviewed articles. Since joining Flagship in 2009, Geoff has co-founded companies that have, in aggregate, achieved over $10 billion in public and private market capitalization including: Generate Biomedicines, Tessera Therapeutics, Indigo Agriculture, Sana Biotechnology (NASDAQ: SANA), Seres Therapeutics (NASDAQ:MCRB), and Axcella Health (NASDAQ:AXLA).

Geoff has received numerous awards and honors, including Bloomberg 50's Ones to Watch; Business Insider’s 30 Biotech Leaders Under 40; and the prestigious Lemelson-MIT Student Prize, awarded to the most innovative students at MIT. Geoff earned his PhD in biomedical engineering and medical physics from MIT under the mentorship of Sangeeta N. Bhatia, MD, PhD; an MS in bioengineering from the University of California, San Diego; and an SB in chemical engineering from MIT.